Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

LCTX Stock Annual Cash Flow. Download in Excel

Lineage Cell Therapeutics, Inc. logo

Lineage Cell Therapeutics, Inc.

Sector: Manufacturing   

Industry: Biological Product (except Diagnostic) Manufacturing

0.96
 
USD
  
-0.11
  
(-9.88%)
Previous close: 1.07  Open: 1.05  Bid: 0.9667  Ask: 0.9765
52 week range    
0.37   
   1.15
Mkt Cap: 247 M  Avg Vol (90 Days): 1,765,875
Last updated: Friday 27th June 2025

Stock Rankings

66
MarketXLS Rank
83
Technical
50
Quality
How are these ranks calculated?
Financials

LCTX Cash Flow

Annual
Dec-14Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23Dec-24
AssetImpairmentCharge9000.0
CapitalExpenditureReported702000.03 M1 M1 M440000.064000.0340000.0413000.0565000.0
CashFlowFromContinuingInvestingActivities-1 M-3 M-1 M-10 M17 M13 M10 M-46 M46 M-2 M
ChangeInAccountPayable-470000.012000.01 M1 M-3 M308000.022 M-19 M-2 M-2 M
ChangeInPayablesAndAccruedExpense-470000.012000.01 M1 M-3 M308000.022 M-19 M-2 M-2 M
ChangeInPrepaidAssets-86000.0-1 M145000.0-437000.0-260000.02 M-72000.0446000.0-418000.0489000.0
ChangeInWorkingCapital-903000.0-972000.02 M621000.0-2 M1 M21 M19 M-11 M-9 M
ChangesInAccountReceivables-74000.0187000.0-172000.046000.0467000.0287000.0-857000.050 M-446000.0106000.0
CommonStockPayments-356000.0-1 M-106000.0
DepreciationAndAmortization9 M5 M4 M3 M3 M2 M873000.0682000.0692000.0609000.0
EarningsLossesFromEquityInvestments5 M-3 M2 M176000.08000.0
FinancingCashFlow64 M33 M55 M6 M617000.030 M37 M2 M6 M36 M
GainLossOnInvestmentSecurities-1 M-3 M-5 M
GainLossOnSaleOfPPE-2 M-105000.0273000.0-20000.024000.0-11000.0
InterestPaidSupplementalData91000.094000.0156000.0155000.028000.020000.013000.013000.0
IssuanceOfCapitalStock44 M20 M49 M103000.05 M31 M148000.0
IssuanceOfDebt471000.02 M172000.0-101000.0-70000.025 M-32000.0-54000.0
NetBusinessPurchaseAndSale-4 M-8 M3 M
NetCommonStockIssuance44 M20 M49 M103000.05 M30 M42000.0
NetForeignCurrencyExchangeGainLoss2 M602000.0
NetInvestmentPropertiesPurchaseAndSale-315000.013000.0-201000.0-8000.014 M13 M10 M-46 M-16 M-2 M
NetInvestmentPurchaseAndSale-315000.013000.0-201000.0-8000.014 M13 M10 M-46 M-16 M-2 M
NetIssuancePaymentsOfDebt471000.02 M172000.0-101000.0-70000.025 M-32000.0-54000.0
NetLongTermDebtIssuance471000.02 M172000.0-101000.0-70000.025 M-32000.0-54000.0
NetPPEPurchaseAndSale-693000.0-3 M-1 M-1 M-358000.0-41000.0-340000.0-413000.0-565000.0
NetPreferredStockIssuance4 M
Other non-cash items5 M13 M3 M-66 M-11 M-889000.0-2 M4 M5 M4 M
PreferredStockIssuance4 M
ProceedsFromIssuanceOfWarrants50.0991000.0
ProceedsFromStockOptionExercised227000.02 M25000.07 M648000.0229000.0
PurchaseOfInvestment-189000.0-53 M-16 M-9 M
PurchaseOfPPE-702000.0-3 M-1 M-1 M-440000.0-64000.0-340000.0-413000.0-565000.0
RepaymentOfDebt-145000.0-253000.0-101000.0-70000.0-32000.0-54000.0
SaleOfBusiness-4 M-6 M
SaleOfInvestment14 M13 M10 M8 M196000.07 M
SaleOfPPE9000.0200000.082000.023000.014000.0
StockBasedCompensation4 M8 M4 M5 M4 M2 M4 M4 M5 M5 M
UnrealizedGainLossOnInvestmentSecurities-15 M-225000.0-2000.0-2 M
amord8 M4 M2 M2 M2 M1 M210000.0100000.0130000.022000.0
begcash5 M42 M23 M38 M24 M10 M33 M56 M
capex-693000.0-3 M-1 M-1 M-358000.0-41000.0-340000.0-413000.0-565000.0
cffcf64 M33 M55 M6 M617000.030 M37 M2 M6 M36 M
cffinv-1 M-3 M-10 M12 M17 M13 M10 M-46 M46 M-2 M
cffoa-39 M41 M-6 M-109 M-32 M-20 M-24 M1 M-29 M-23 M
chgcash24 M71 M15 M-13 M-14 M23 M23 M-43 M24 M10 M
chginv-87000.0
chgothca-56000.0-22000.0-487000.0
chgothcl-186000.076000.016000.0-143000.0380000.0-13 M-8 M-8 M
chgothwc-49 M
chgpay-470000.012000.01 M1 M-3 M308000.022 M-19 M-2 M-2 M
chgrec-74000.0187000.0985000.0101000.01 M-714000.0-857000.050 M-446000.0106000.0
comstkiss44 M20 M49 M103000.05 M31 M148000.0
definc-7 M-1 M-2 M
deftax-7 M-1 M-2 M
depamor9 M5 M4 M3 M3 M2 M663000.0682000.0562000.0587000.0
effexch230000.0292000.0101000.06000.070000.0-63000.0-20000.0-873000.0-95000.0
endcash29 M114 M37 M24 M10 M33 M56 M12 M-45 M46 M
fcf-40 M38 M-32 M-32 M-32 M-20 M-24 M646000.0-29 M-24 M
ltdebtiss471000.02 M425000.025 M
ltdebtpay-145000.0-253000.0-101000.0-70000.0-32000.0-54000.0
netinccont-44 M19 M-17 M-45 M-12 M-21 M-43 M-26 M-21 M-19 M
netothfin15 M9 M6 M6 M584000.025 M-74000.0-17000.0-194000.0
netothinv-315000.013000.0-12000.0-8000.0-17000.018000.0
opcf-39 M41 M-31 M-31 M-32 M-20 M-24 M1 M-29 M-23 M
opgainloss5 M1 M-1 M-3 M-20000.0-499000.04 M176000.08000.0
purchbus-2 M3 M
purchsti-189000.0-53 M-16 M-9 M
repurchstk-356000.0-1 M-106000.0
salelti14 M13 M10 M8 M
salesti8 M196000.07 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader